Cartesian Therapeutics, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
RNAC on Nasdaq
Industry
Pharmaceutical Preparations
Location
7495 New Horizon Way, Frederick, MD

Insiders trading volume in the past year

Cartesian Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Elizabeth Hoge 10%+ Owner $121M Oct 11, 2024
Timothy A. Springer Director, 10%+ Owner $104M +$16M +18.2% Apr 9, 2025
Murat Kalayoglu Director, 10%+ Owner $16.7M Jan 2, 2025
Carsten Brunn President and CEO, Director $3.44M -$290K -7.78% Jan 3, 2025
Peter G. Traber Chief Medical Officer $1.64M Sep 25, 2023
Blaine Davis Chief Financial Officer $1.6M -$134K -7.75% Jan 3, 2025
Metin Kurtoglu Chief Technology Officer $1.11M -$2.51M -69.4% Jan 3, 2025
Lloyd P. Johnston Chief Operations Officer $922K Jan 4, 2023
Takashi Kei Kishimoto Chief Scientific Officer $839K May 30, 2023
Michael Singer Director $639K Jan 2, 2025
Milos Miljkovic Chief Medical Officer $620K -$939K -60.2% Jan 3, 2025
Aymeric Sallin Director $547K Jan 2, 2024
Kevin Tan Chief Financial Officer $427K Jan 3, 2022
Christopher Jewell Chief Scientific Officer $255K -$918K -78.3% Jan 10, 2025
Emily English Chief Operations Officer $196K -$30.1K -13.3% Apr 15, 2025
Timothy C. Barabe Director $86.6K +$95.3K Jan 2, 2025
Goran Ando Director $59.3K Jan 2, 2023
Carrie Smith Cox Director $57.9K Jan 2, 2025
Zenner Patrick J Director $40.4K Jan 2, 2025
Nishan DeSilva Director $35.1K Jan 2, 2025
Kemal Malik Director $34.3K Jan 2, 2025
Ann K. Donohue VP Finance $8.63K May 27, 2021
Scott Myers Director Nov 13, 2023

Recent Insider Transactions by Companies or Individuals for Cartesian Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.